Cefuroxime compared to amoxicillin - clavulanic acid in the treatment of community-acquired pneumonia

Singapore Medical Journal

Volumn 37, Issue 3, 1996, Pages 255-257

  Oh, H M L ^a,b   Ng, A W K ^a   Lee, S K ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Amoxicillin clavulanic acid; Bacterial pneumonia; Cefuroxime

Indexed keywords

AMOXICILLIN; CEFUROXIME; CLAVULANIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA; MALE; MYCOPLASMA; ORAL DRUG ADMINISTRATION; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS;

ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFUROXIME; CEPHALOSPORINS; CLAVULANIC ACID; CLAVULANIC ACIDS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PENICILLINS; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME;

EID: 0029785503     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Williams PEO, Harding SM. The absolute bioavailability of oral cefuroxirae axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother 1984; 13: 191-6.
2. Todd PA, Benfield P. Amoxillin/clavulanic acid: an update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1990; 39(2): 264-307.
3. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 1990; 69: 307-16.
4. Powell M, Koutsia Carouzou C, Vontsinas D, Seymour A, Williams JD. Resistance of clinical isolates of Haemophilus influenzae in UK 1986. Br Med J 1987; 295: 176-9.
5. Calder MA, Croughan MJ, Mcleod DT, Ahmad F. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections. Drugs 1986; 31 (Suppl 3): 11-6.
6. O'Donoran C, Fitzgerald MX, Fiavell-Matts SG, Howell F, Mckenzie A, Whittaker J. Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients. Br J Clin Prac 1987; 41(12): 1044-52.
7. Landau Z, Schlaffer F, Pitlik S. Cefuroxime axetil vs augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease. Isr J Med Sci 1992; 28: 797-9.